TMAO, produced in the gut when red meat and high-fat dairy are broken down, identified patients with rapidly growing AAAs.

These randomized results are encouraging, although the field awaits longer-term data to see how the leads hold up.

Transcatheter devices are new to the heart failure (HF) community and treatment armamentarium for severe MR. This discussion focuses on the impact of transcatheter devices on HF patients and current ...

Longer-term studies will be needed to track whether per-patient costs might drop over time with continued use of the meds.

With so many options available for addressing the disease, it shouldn’t be accepted as inevitable, a scientific statement ...

New US hypertension guidelines, the first since 2017, released today reinforce prior recommendations that prioritize lowering ...

The study can’t supplant an RCT in this space, but does provide clear support for both short DAPT and P2Y12 inhibitors ...

Yet 44% of the high-risk patients, from LAAO’s early era, died by 5 years—researchers say this knowledge can aid ...

Japanese registry data point to fewer deaths and heart failure hospitalizations, especially when MR is reduced to mild or ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...

Effects are more modest in placebo-controlled versus nonrandomized studies, with experts calling for further research.

In-store opportunities for patients to check in with their health may offer touchpoints to those who don’t regularly seek ...